• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For February 28, 2023

    2/28/23 4:34:56 AM ET
    $NFE
    $NNI
    $NRDY
    $NSTG
    Oil/Gas Transmission
    Utilities
    Finance: Consumer Services
    Finance
    Get the next $NFE alert in real time by email

    Companies Reporting Before The Bell

    • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

    • MINISO Group Holding (NYSE:MNSO) is expected to report quarterly earnings at $0.13 per share on revenue of $364.68 million.

    • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is likely to report quarterly loss at $0.22 per share on revenue of $45.83 million.

    • TG Therapeutics (NASDAQ:TGTX) is expected to report quarterly loss at $0.26 per share on revenue of $1.83 million.

    • Compass Pathways (NASDAQ:CMPS) is likely to report earnings for its fourth quarter.

    • Black Knight (NYSE:BKI) is projected to report quarterly earnings at $0.54 per share on revenue of $387.84 million.

    • BlackRock TCP Cap (NASDAQ:TCPC) is projected to report quarterly earnings at $0.39 per share on revenue of $46.68 million.

    • Sculptor Cap (NYSE:SCU) is likely to report quarterly earnings at $0.17 per share on revenue of $101.45 million.

    • Pacira BioSciences (NASDAQ:PCRX) is expected to report quarterly earnings at $0.83 per share on revenue of $173.50 million.

    • Perficient (NASDAQ:PRFT) is projected to report quarterly earnings at $1.13 per share on revenue of $236.02 million.

    • Cracker Barrel Old (NASDAQ:CBRL) is estimated to report quarterly earnings at $1.36 per share on revenue of $917.47 million.

    • Heska (NASDAQ:HSKA) is projected to report quarterly loss at $0.04 per share on revenue of $64.66 million.

    • Delek Logistics Partners (NYSE:DKL) is likely to report quarterly earnings at $1.09 per share on revenue of $294.15 million.

    • Delek US Hldgs (NYSE:DK) is projected to report quarterly earnings at $0.87 per share on revenue of $3.34 billion.

    • Spirit Realty Cap (NYSE:SRC) is projected to report earnings for its fourth quarter.

    • Cronos Group (NASDAQ:CRON) is projected to report quarterly loss at $0.07 per share on revenue of $32.02 million.

    • Target Hospitality (NASDAQ:TH) is likely to report quarterly loss at $0.10 per share on revenue of $28.90 million.

    • Beauty Health (NASDAQ:SKIN) is projected to report quarterly earnings at $0.04 per share on revenue of $94.61 million.

    • Jones Lang LaSalle (NYSE:JLL) is estimated to report quarterly earnings at $4.44 per share on revenue of $2.26 billion.

    • Altimmune (NASDAQ:ALT) is expected to report quarterly loss at $0.50 per share on revenue of $30 thousand.

    • JM Smucker (NYSE:SJM) is estimated to report quarterly earnings at $2.12 per share on revenue of $2.22 billion.

    • Bentley Systems (NASDAQ:BSY) is estimated to report quarterly earnings at $0.19 per share on revenue of $279.98 million.

    • Norwegian Cruise Line (NYSE:NCLH) is likely to report quarterly loss at $0.85 per share on revenue of $1.50 billion.

    • Dorman Products (NASDAQ:DORM) is expected to report quarterly earnings at $1.08 per share on revenue of $449.42 million.

    • Builders FirstSource (NYSE:BLDR) is estimated to report quarterly earnings at $2.36 per share on revenue of $4.26 billion.

    • Nexstar Media Group (NASDAQ:NXST) is likely to report quarterly earnings at $8.26 per share on revenue of $1.50 billion.

    • Clear Channel Outdoor (NYSE:CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $705.50 million.

    • AutoZone (NYSE:AZO) is expected to report quarterly earnings at $21.91 per share on revenue of $3.56 billion.

    • Olaplex Hldgs (NASDAQ:OLPX) is estimated to report quarterly earnings at $0.06 per share on revenue of $138.98 million.

    • Warby Parker (NYSE:WRBY) is estimated to report quarterly earnings at $0.00 per share on revenue of $142.51 million.

    • Intl Game Tech (NYSE:IGT) is likely to report quarterly earnings at $0.29 per share on revenue of $1.03 billion.

    • Playtika Holding (NASDAQ:PLTK) is estimated to report quarterly earnings at $0.17 per share on revenue of $627.65 million.

    • Easterly Government Props (NYSE:DEA) is estimated to report earnings for its fourth quarter.

    • Privia Health Group (NASDAQ:PRVA) is expected to report quarterly loss at $0.03 per share on revenue of $587.13 million.

    • Civeo (NYSE:CVEO) is projected to report quarterly loss at $0.61 per share on revenue of $145.96 million.

    • Advance Auto Parts (NYSE:AAP) is expected to report quarterly earnings at $2.39 per share on revenue of $2.42 billion.

    • Target (NYSE:TGT) is projected to report quarterly earnings at $1.40 per share on revenue of $30.67 billion.

    • Golar LNG (NASDAQ:GLNG) is estimated to report quarterly earnings at $0.53 per share on revenue of $79.05 million.

    • Bank of Nova Scotia (NYSE:BNS) is likely to report quarterly earnings at $2.03 per share on revenue of $8.27 billion.

    • New Fortress Energy (NASDAQ:NFE) is expected to report quarterly earnings at $0.53 per share on revenue of $734.38 million.

    • Thoughtworks Holding (NASDAQ:TWKS) is estimated to report quarterly earnings at $0.09 per share on revenue of $306.40 million.

    • Aurinia Pharmaceuticals (NASDAQ:AUPH) is likely to report quarterly loss at $0.27 per share on revenue of $27.78 million.

    • Dentsply Sirona (NASDAQ:XRAY) is projected to report quarterly earnings at $0.32 per share on revenue of $941.37 million.

    • First Advantage (NASDAQ:FA) is likely to report quarterly earnings at $0.29 per share on revenue of $217.44 million.

    • Interface (NASDAQ:TILE) is likely to report quarterly earnings at $0.27 per share on revenue of $338.00 million.

    • Bank of Montreal (NYSE:BMO) is estimated to report quarterly earnings at $3.18 per share on revenue of $7.29 billion.

    • Frontline (NYSE:FRO) is expected to report quarterly earnings at $1.06 per share on revenue of $365.02 million.

    • Perimeter Solutions (NYSE:PRM) is projected to report quarterly loss at $0.13 per share on revenue of $40.77 million.

    • ADC Therapeutics (NYSE:ADCT) is estimated to report quarterly loss at $0.29 per share on revenue of $65.49 million.

    • Daqo New Energy (NYSE:DQ) is estimated to report quarterly earnings at $7.37 per share on revenue of $987.83 million.

    • Mersana Therapeutics (NASDAQ:MRSN) is projected to report quarterly loss at $0.50 per share on revenue of $15.28 million.

    • Gogo (NASDAQ:GOGO) is estimated to report quarterly earnings at $0.16 per share on revenue of $107.10 million.

    • ADT (NYSE:ADT) is projected to report quarterly earnings at $0.18 per share on revenue of $1.62 billion.

    • Nuwellis (NASDAQ:NUWE) is likely to report quarterly loss at $24.65 per share on revenue of $2.20 million.

    • Veritiv (NYSE:VRTV) is expected to report quarterly earnings at $5.44 per share on revenue of $1.75 billion.

    • eHealth (NASDAQ:EHTH) is estimated to report quarterly earnings at $0.56 per share on revenue of $185.95 million.

    • Clover Health Investments (NASDAQ:CLOV) is likely to report quarterly loss at $0.25 per share on revenue of $785.38 million.

    • Consolidated Comms Hldgs (NASDAQ:CNSL) is likely to report quarterly loss at $0.17 per share on revenue of $287.23 million.

    • Ituran Location & Control (NASDAQ:ITRN) is likely to report quarterly earnings at $0.52 per share on revenue of $74.60 million.

    • Chico's FAS (NYSE:CHS) is estimated to report earnings for its fourth quarter.

    • Sempra Energy (NYSE:SRE) is estimated to report quarterly earnings at $2.04 per share on revenue of $3.79 billion.

    • Shift4 Payments (NYSE:FOUR) is projected to report quarterly earnings at $0.38 per share on revenue of $545.62 million.

    • Hayward Holdings (NYSE:HAYW) is likely to report quarterly earnings at $0.12 per share on revenue of $260.17 million.

    • International Seaways (NYSE:INSW) is expected to report quarterly earnings at $3.64 per share on revenue of $310.01 million.

    • FTC Solar (NASDAQ:FTCI) is projected to report quarterly loss at $0.11 per share on revenue of $30.38 million.

    • Ocwen Financial (NYSE:OCN) is projected to report quarterly loss at $0.44 per share on revenue of $254.49 million.

    • Fusion Fuel Green (NASDAQ:HTOO) is likely to report earnings for its fourth quarter.

    • Owens & Minor (NYSE:OMI) is estimated to report earnings for its fourth quarter.

    • Ocugen (NASDAQ:OCGN) is estimated to report quarterly loss at $0.10 per share on revenue of $2.60 million.

    • Sotera Health (NASDAQ:SHC) is projected to report quarterly earnings at $0.22 per share on revenue of $247.55 million.

    • Kontoor Brands (NYSE:KTB) is projected to report quarterly earnings at $0.67 per share on revenue of $668.80 million.

    • RadNet (NASDAQ:RDNT) is expected to report quarterly earnings at $0.15 per share on revenue of $347.27 million.

    • Vertex Energy (NASDAQ:VTNR) is expected to report quarterly earnings at $0.40 per share on revenue of $912.58 million.

    • Theratechnologies (NASDAQ:THTX) is likely to report quarterly loss at $0.08 per share on revenue of $21.42 million.

    • American Woodmark (NASDAQ:AMWD) is estimated to report quarterly earnings at $1.78 per share on revenue of $511.95 million.

    • Mondee Hldgs (NASDAQ:MOND) is projected to report quarterly loss at $0.07 per share on revenue of $38.12 million.

    • Carrols Restaurant Group (NASDAQ:TAST) is expected to report quarterly loss at $0.21 per share on revenue of $438.69 million.

    • XPEL (NASDAQ:XPEL) is estimated to report quarterly earnings at $0.44 per share on revenue of $84.14 million.

    • Zevia (NYSE:ZVIA) is expected to report quarterly loss at $0.15 per share on revenue of $31.01 million.

    • Codere Online Luxembourg (NASDAQ:CDRO) is projected to report earnings for its fourth quarter.

    • Butterfly Network (NYSE:BFLY) is estimated to report quarterly loss at $0.22 per share on revenue of $19.93 million.

    • Allot (NASDAQ:ALLT) is estimated to report quarterly loss at $0.16 per share on revenue of $33.54 million.

    • Ecovyst (NYSE:ECVT) is expected to report quarterly earnings at $0.23 per share on revenue of $189.45 million.

    • Lindblad Expeditions (NASDAQ:LIND) is estimated to report quarterly loss at $0.46 per share on revenue of $94.26 million.

    • Mallinckrodt (AMEX:MNK) is likely to report earnings for its fourth quarter.

    • Sibanye Stillwater (NYSE:SBSW) is projected to report earnings for its Fiscal Year 2022.

    • Itau Corpbanca (NYSE:ITCB) is expected to report earnings for its fourth quarter.

    • SeaWorld Entertainment (NYSE:SEAS) is estimated to report quarterly earnings at $0.73 per share on revenue of $382.08 million.

    • HUTCHMED (China) (NASDAQ:HCM) is expected to report earnings for its Fiscal Year 2022.

    • MultiPlan (NYSE:MPLN) is projected to report quarterly loss at $0.05 per share on revenue of $240.04 million.

    • APi Gr (NYSE:APG) is estimated to report quarterly earnings at $0.34 per share on revenue of $1.63 billion.

    Companies Reporting After The Bell

    • Buenaventura Mining Co (NYSE:BVN) is likely to report earnings for its fourth quarter.

    • Enviva (NYSE:EVA) is expected to report quarterly earnings at $0.57 per share on revenue of $422.30 million.

    • MBIA (NYSE:MBI) is estimated to report quarterly loss at $0.31 per share on revenue of $6.00 million.

    • Jackson Finl (NYSE:JXN) is expected to report quarterly earnings at $5.21 per share on revenue of $1.57 billion.

    • Ryan Specialty Holdings (NYSE:RYAN) is expected to report quarterly earnings at $0.26 per share on revenue of $427.63 million.

    • Urban Outfitters (NASDAQ:URBN) is estimated to report quarterly earnings at $0.38 per share on revenue of $1.37 billion.

    • Regenxbio (NASDAQ:RGNX) is projected to report quarterly loss at $1.23 per share on revenue of $37.45 million.

    • Smart Sand (NASDAQ:SND) is likely to report quarterly earnings at $0.00 per share on revenue of $65.70 million.

    • Novavax (NASDAQ:NVAX) is expected to report quarterly loss at $0.92 per share on revenue of $383.14 million.

    • Vroom (NASDAQ:VRM) is estimated to report quarterly loss at $0.69 per share on revenue of $268.22 million.

    • Rocket Companies (NYSE:RKT) is expected to report quarterly loss at $0.11 per share on revenue of $682.73 million.

    • Virgin Galactic Hldgs (NYSE:SPCE) is expected to report quarterly loss at $0.51 per share on revenue of $370 thousand.

    • Quotient Technology (NYSE:QUOT) is projected to report earnings for its fourth quarter.

    • The RealReal (NASDAQ:REAL) is expected to report quarterly loss at $0.35 per share on revenue of $157.68 million.

    • Ambarella (NASDAQ:AMBA) is expected to report quarterly earnings at $0.15 per share on revenue of $83.30 million.

    • Alexandria Real Estate (NYSE:ARE) is likely to report quarterly earnings at $0.20 per share on revenue of $1.16 billion.

    • PROCEPT BioRobotics (NASDAQ:PRCT) is likely to report quarterly loss at $0.54 per share on revenue of $23.01 million.

    • Blink Charging (NASDAQ:BLNK) is likely to report quarterly loss at $0.48 per share on revenue of $19.11 million.

    • Cutera (NASDAQ:CUTR) is likely to report quarterly loss at $0.24 per share on revenue of $68.24 million.

    • Ecopetrol (NYSE:EC) is expected to report quarterly earnings at $1.13 per share on revenue of $9.68 billion.

    • Myriad Genetics (NASDAQ:MYGN) is estimated to report quarterly loss at $0.16 per share on revenue of $169.46 million.

    • Big 5 Sporting Goods (NASDAQ:BGFV) is estimated to report quarterly earnings at $0.07 per share on revenue of $238.29 million.

    • eXp World Holdings (NASDAQ:EXPI) is projected to report quarterly loss at $0.02 per share on revenue of $1.06 billion.

    • Monster Beverage (NASDAQ:MNST) is likely to report quarterly earnings at $0.63 per share on revenue of $1.60 billion.

    • Natera (NASDAQ:NTRA) is expected to report quarterly loss at $1.42 per share on revenue of $215.55 million.

    • Service Properties Trust (NASDAQ:SVC) is projected to report earnings for its fourth quarter.

    • Eos Energy Enterprises (NASDAQ:EOSE) is likely to report quarterly loss at $0.72 per share on revenue of $2.99 million.

    • Omnicell (NASDAQ:OMCL) is likely to report quarterly earnings at $0.09 per share on revenue of $287.43 million.

    • Assured Guaranty (NYSE:AGO) is estimated to report quarterly earnings at $0.89 per share on revenue of $190.21 million.

    • Ambac Financial Group (NYSE:AMBC) is projected to report quarterly earnings at $0.88 per share on revenue of $130.40 million.

    • Ross Stores (NASDAQ:ROST) is projected to report quarterly earnings at $1.24 per share on revenue of $5.17 billion.

    • Cosan (NYSE:CSAN) is expected to report quarterly loss at $0.02 per share on revenue of $4.12 billion.

    • PetIQ (NASDAQ:PETQ) is estimated to report quarterly loss at $0.09 per share on revenue of $192.47 million.

    • CarGurus (NASDAQ:CARG) is projected to report quarterly earnings at $0.10 per share on revenue of $281.41 million.

    • Skyward Specialty (NASDAQ:SKWD) is projected to report quarterly earnings at $0.26 per share on revenue of $173.54 million.

    • Arcutis Biotherapeutics (NASDAQ:ARQT) is projected to report quarterly loss at $1.42 per share on revenue of $2.20 million.

    • Compass (NYSE:COMP) is estimated to report quarterly loss at $0.33 per share on revenue of $1.19 billion.

    • Axon Enterprise (NASDAQ:AXON) is estimated to report quarterly earnings at $0.51 per share on revenue of $305.87 million.

    • Rocket Lab USA (NASDAQ:RKLB) is expected to report quarterly loss at $0.07 per share on revenue of $49.24 million.

    • Alphatec Holdings (NASDAQ:ATEC) is expected to report quarterly loss at $0.28 per share on revenue of $100.92 million.

    • Rivian Automotive (NASDAQ:RIVN) is estimated to report quarterly loss at $1.94 per share on revenue of $747.39 million.

    • Accel Entertainment (NYSE:ACEL) is estimated to report quarterly earnings at $0.22 per share on revenue of $275.42 million.

    • Solid Power (NASDAQ:SLDP) is projected to report quarterly loss at $0.10 per share on revenue of $950 thousand.

    • Amphastar Pharmaceuticals (NASDAQ:AMPH) is expected to report quarterly earnings at $0.41 per share on revenue of $126.98 million.

    • Atea Pharmaceuticals (NASDAQ:AVIR) is estimated to report earnings for its fourth quarter.

    • Syndax Pharmaceuticals (NASDAQ:SNDX) is likely to report quarterly loss at $0.65 per share on revenue of $370 thousand.

    • Southwest Gas Hldgs (NYSE:SWX) is expected to report quarterly earnings at $1.58 per share on revenue of $1.20 billion.

    • Fabrinet (NYSE:FN) is expected to report quarterly earnings at $0.64 per share on revenue of $194.00 million.

    • Marchex (NASDAQ:MCHX) is projected to report quarterly loss at $0.02 per share on revenue of $12.90 million.

    • MiMedx Group (NASDAQ:MDXG) is estimated to report quarterly loss at $0.04 per share on revenue of $74.53 million.

    • Arteris (NASDAQ:AIP) is likely to report quarterly loss at $0.20 per share on revenue of $11.32 million.

    • Rogers (NYSE:ROG) is estimated to report quarterly earnings at $0.86 per share on revenue of $235.40 million.

    • Revance Therapeutics (NASDAQ:RVNC) is projected to report quarterly loss at $0.95 per share on revenue of $46.55 million.

    • Microvision (NASDAQ:MVIS) is estimated to report earnings for its fourth quarter.

    • Iovance Biotherapeutics (NASDAQ:IOVA) is estimated to report earnings for its fourth quarter.

    • Arcus Biosciences (NYSE:RCUS) is estimated to report quarterly loss at $1.07 per share on revenue of $23.31 million.

    • Sarepta Therapeutics (NASDAQ:SRPT) is estimated to report quarterly loss at $1.35 per share on revenue of $248.34 million.

    • Allogene Therapeutics (NASDAQ:ALLO) is projected to report quarterly loss at $0.70 per share on revenue of $60 thousand.

    • Marathon Digital Holdings (NASDAQ:MARA) is estimated to report quarterly loss at $0.16 per share on revenue of $34.95 million.

    • comScore (NASDAQ:SCOR) is expected to report quarterly loss at $0.07 per share on revenue of $95.53 million.

    • Talos Energy (NYSE:TALO) is estimated to report quarterly earnings at $0.73 per share on revenue of $345.44 million.

    • Horizon Tech Finance (NASDAQ:HRZN) is projected to report quarterly earnings at $0.39 per share on revenue of $23.06 million.

    • Gulfport Energy (NYSE:GPOR) is projected to report quarterly earnings at $2.30 per share on revenue of $320.67 million.

    • First Solar (NASDAQ:FSLR) is projected to report quarterly loss at $0.15 per share on revenue of $989.28 million.

    • GoodRx Holdings (NASDAQ:GDRX) is estimated to report quarterly earnings at $0.05 per share on revenue of $178.60 million.

    • Red Robin Gourmet Burgers (NASDAQ:RRGB) is expected to report quarterly loss at $0.62 per share on revenue of $289.01 million.

    • FIGS (NYSE:FIGS) is expected to report quarterly earnings at $0.01 per share on revenue of $135.43 million.

    • Health Catalyst (NASDAQ:HCAT) is estimated to report quarterly loss at $0.11 per share on revenue of $68.26 million.

    • B&G Foods (NYSE:BGS) is likely to report quarterly earnings at $0.22 per share on revenue of $583.90 million.

    • Grocery Outlet Holding (NASDAQ:GO) is projected to report quarterly earnings at $0.23 per share on revenue of $906.51 million.

    • Inter Parfums (NASDAQ:IPAR) is projected to report quarterly earnings at $0.29 per share on revenue of $294.02 million.

    • Clean Energy Fuels (NASDAQ:CLNE) is projected to report quarterly earnings at $0.01 per share on revenue of $123.41 million.

    • Jamf Holding (NASDAQ:JAMF) is likely to report quarterly earnings at $0.04 per share on revenue of $128.90 million.

    • ON24 (NYSE:ONTF) is likely to report quarterly loss at $0.09 per share on revenue of $46.15 million.

    • Payoneer Global (NASDAQ:PAYO) is estimated to report quarterly loss at $0.05 per share on revenue of $171.53 million.

    • Alexander & Baldwin (NYSE:ALEX) is likely to report quarterly earnings at $0.20 per share on revenue of $95.40 million.

    • SmileDirectClub (NASDAQ:SDC) is estimated to report quarterly loss at $0.21 per share on revenue of $90.62 million.

    • PubMatic (NASDAQ:PUBM) is expected to report quarterly earnings at $0.26 per share on revenue of $76.71 million.

    • Flywire (NASDAQ:FLYW) is likely to report quarterly loss at $0.10 per share on revenue of $67.79 million.

    • Whitestone REIT (NYSE:WSR) is estimated to report quarterly earnings at $0.06 per share on revenue of $35.76 million.

    • ICF International (NASDAQ:ICFI) is likely to report quarterly earnings at $1.52 per share on revenue of $472.27 million.

    • Mirati Therapeutics (NASDAQ:MRTX) is expected to report quarterly loss at $3.55 per share on revenue of $2.27 million.

    • NanoString Technologies (NASDAQ:NSTG) is likely to report quarterly loss at $0.58 per share on revenue of $33.71 million.

    • Nerdy (NYSE:NRDY) is likely to report quarterly loss at $0.16 per share on revenue of $39.93 million.

    • 3D Sys (NYSE:DDD) is expected to report quarterly loss at $0.08 per share on revenue of $133.94 million.

    • Duolingo (NASDAQ:DUOL) is expected to report quarterly loss at $0.53 per share on revenue of $99.91 million.

    • Nextdoor Holdings (NYSE:KIND) is expected to report quarterly loss at $0.09 per share on revenue of $50.75 million.

    • AMC Entertainment (NYSE:AMC) is expected to report quarterly loss at $0.19 per share on revenue of $1.01 billion.

    • Coupang (NYSE:CPNG) is estimated to report quarterly earnings at $0.05 per share on revenue of $5.40 billion.

    • Mayville Engineering (NYSE:MEC) is likely to report quarterly earnings at $0.13 per share on revenue of $123.72 million.

    • OrthoPediatrics (NASDAQ:KIDS) is likely to report quarterly loss at $0.25 per share on revenue of $32.62 million.

    • Global Medical REIT (NYSE:GMRE) is likely to report quarterly earnings at $0.03 per share on revenue of $35.95 million.

    • Fate Therapeutics (NASDAQ:FATE) is projected to report quarterly loss at $0.86 per share on revenue of $16.72 million.

    • Supernus Pharmaceuticals (NASDAQ:SUPN) is projected to report quarterly earnings at $0.68 per share on revenue of $180.37 million.

    • VIZIO Holding (NYSE:VZIO) is likely to report quarterly earnings at $0.02 per share on revenue of $510.69 million.

    • Shoals Technologies Gr (NASDAQ:SHLS) is projected to report quarterly earnings at $0.08 per share on revenue of $85.96 million.

    • Nelnet (NYSE:NNI) is projected to report quarterly earnings at $1.57 per share on revenue of $337.04 million.

    • Alignment Healthcare (NASDAQ:ALHC) is estimated to report quarterly loss at $0.30 per share on revenue of $341.11 million.

    • Endeavor Gr Hldgs (NYSE:EDR) is likely to report quarterly earnings at $0.19 per share on revenue of $1.27 billion.

    • UMH Properties (NYSE:UMH) is expected to report quarterly loss at $0.01 per share on revenue of $51.68 million.

    • Marqeta (NASDAQ:MQ) is projected to report quarterly loss at $0.09 per share on revenue of $201.93 million.

    • Franchise Group (NASDAQ:FRG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.03 billion.

    • Montrose Environmental Gr (NYSE:MEG) is estimated to report quarterly loss at $0.26 per share on revenue of $141.24 million.

    • Cerus (NASDAQ:CERS) is expected to report quarterly loss at $0.05 per share on revenue of $45.96 million.

    • Hyliion Holdings (NYSE:HYLN) is projected to report quarterly loss at $0.20 per share on revenue of $790 thousand.

    • Corcept Therapeutics (NASDAQ:CORT) is estimated to report quarterly earnings at $0.22 per share on revenue of $105.08 million.

    • Fulgent Genetics (NASDAQ:FLGT) is expected to report quarterly loss at $0.56 per share on revenue of $59.57 million.

    • Masimo (NASDAQ:MASI) is expected to report quarterly earnings at $1.17 per share on revenue of $602.49 million.

    • Huron Consulting Gr (NASDAQ:HURN) is estimated to report quarterly earnings at $0.99 per share on revenue of $282.35 million.

    • Invitae (NYSE:NVTA) is estimated to report quarterly loss at $0.53 per share on revenue of $121.28 million.

    • Luxfer Holdings (NYSE:LXFR) is estimated to report quarterly earnings at $0.31 per share on revenue of $101.25 million.

    • Schrodinger (NASDAQ:SDGR) is projected to report quarterly loss at $0.53 per share on revenue of $47.43 million.

    • Forge Global Holdings (NYSE:FRGE) is projected to report quarterly loss at $0.15 per share on revenue of $17.88 million.

    • Cytek Biosciences (NASDAQ:CTKB) is projected to report quarterly earnings at $0.05 per share on revenue of $50.22 million.

    • Eventbrite (NYSE:EB) is expected to report quarterly loss at $0.14 per share on revenue of $70.99 million.

    • Castle Biosciences (NASDAQ:CSTL) is projected to report quarterly loss at $0.84 per share on revenue of $37.16 million.

    • Silk Road Medical (NASDAQ:SILK) is likely to report quarterly loss at $0.38 per share on revenue of $37.35 million.

    • Bain Capital Specialty (NYSE:BCSF) is projected to report quarterly earnings at $0.41 per share on revenue of $58.36 million.

    • HP (NYSE:HPQ) is estimated to report earnings for its first quarter.

    • iHeartMedia (NASDAQ:IHRT) is expected to report quarterly earnings at $0.44 per share on revenue of $1.11 billion.

    • Verisk Analytics (NASDAQ:VRSK) is likely to report quarterly earnings at $1.18 per share on revenue of $616.33 million.

    • Agilent Technologies (NYSE:A) is expected to report quarterly earnings at $1.30 per share on revenue of $1.70 billion.

    • Doma Holdings (NYSE:DOMA) is estimated to report quarterly loss at $0.10 per share on revenue of $81.08 million.

    • BRP Group (NASDAQ:BRP) is projected to report quarterly earnings at $0.12 per share on revenue of $234.70 million.

    • SLR Investment (NASDAQ:SLRC) is estimated to report quarterly earnings at $0.40 per share on revenue of $53.25 million.

    • Radius Global Infr (NASDAQ:RADI) is projected to report quarterly loss at $0.34 per share on revenue of $34.72 million.

    • OneSpan (NASDAQ:OSPN) is projected to report quarterly loss at $0.07 per share on revenue of $53.19 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $NFE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NFE
    $NNI
    $NRDY
    $NSTG

    CompanyDatePrice TargetRatingAnalyst
    Arcus Biosciences Inc.
    $RCUS
    2/12/2026$23.00Overweight → Equal Weight
    Wells Fargo
    Norwegian Cruise Line Holdings Ltd.
    $NCLH
    2/11/2026$23.00Overweight → Equal Weight
    Barclays
    AutoZone Inc.
    $AZO
    2/9/2026$3900.00Outperform → Neutral
    Robert W. Baird
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Coupang Inc.
    $CPNG
    2/5/2026$17.00Underperform
    Bernstein
    Fabrinet
    $FN
    2/4/2026$540.00Peer Perform → Outperform
    Wolfe Research
    Whitestone REIT
    $WSR
    2/4/2026$16.00Overweight
    Cantor Fitzgerald
    Kontoor Brands Inc.
    $KTB
    2/4/2026$65.00Hold
    Jefferies
    More analyst ratings

    $NFE
    $NNI
    $NRDY
    $NSTG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Malkin Anthony E bought $275,720 worth of shares (7,000 units at $39.39) (SEC Form 4)

    4 - APi Group Corp (0001796209) (Issuer)

    1/9/26 5:11:44 PM ET
    $APG
    Engineering & Construction
    Consumer Discretionary

    Director Pisano Wayne bought $20,410 worth of shares (5,000 units at $4.08), increasing direct ownership by 59% to 13,498 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/9/26 4:10:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Voss Capital, Lp bought $3,203,278 worth of Voting common stock (226,112 units at $14.17) (SEC Form 4)

    4 - Flywire Corp (0001580560) (Issuer)

    1/7/26 5:59:36 PM ET
    $FLYW
    Real Estate

    $NFE
    $NNI
    $NRDY
    $NSTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Mitchell Adrian V

    4 - Warby Parker Inc. (0001504776) (Issuer)

    2/12/26 7:01:12 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form 3 filed by new insider Mitchell Adrian V

    3 - Warby Parker Inc. (0001504776) (Issuer)

    2/12/26 6:59:22 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Chief Financial Officer Vattuone Steven sold $3,342 worth of shares (422 units at $7.92), decreasing direct ownership by 0.09% to 452,654 units (SEC Form 4)

    4 - ON24 INC. (0001110611) (Issuer)

    2/12/26 5:33:39 PM ET
    $ONTF
    Computer Software: Prepackaged Software
    Technology

    $NFE
    $NNI
    $NRDY
    $NSTG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Scotiabank donates $150,000 to support Tumbler Ridge following national tragedy

    TORONTO, Feb. 12, 2026 /CNW/ - Scotiabank is donating $150,000 to organizations that are supporting families and communities in British Columbia following the tragic events in Tumbler Ridge on February 10. "We are devastated to see the news coming out of Tumbler Ridge, in my own home province of B.C.," said Scott Thomson, President and CEO at Scotiabank. "Events like these are rare, especially in Canada, and it is heart-wrenching to think about the impact this will have on local community members and on all Canadians who are mourning alongside them. To our clients, employees,

    2/12/26 5:15:00 PM ET
    $BNS
    Major Banks
    Finance

    Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026

    ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the fourth quarter and full year 2025 financial and business results on Tuesday, February 24, 2026, at 4:30 p.m. ET. Following management's prepared remarks and discussion of

    2/12/26 4:35:00 PM ET
    $SUPN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Fourth Quarter Ended December 31, 2025

    Bain Capital Specialty Finance, Inc. (NYSE:BCSF, the "Company")) today announced it will report its financial results for the fourth quarter and fiscal year ended December 31, 2025 on Thursday, February 26, 2026 after market close. Management will host a conference call on Friday, February 27, 2026 at 8:00 a.m. Eastern Time to discuss the Company's financial results. Conference Call Information: A conference call to discuss the Company's financial results will be held live at 8:00 a.m. Eastern Time on February 27, 2026. Please visit BCSF's webcast link located on the Events & Presentations page of the Investor Resources section of BCSF's website at http://www.baincapitalspecialtyfinance

    2/12/26 4:30:00 PM ET
    $BCSF
    Finance/Investors Services
    Finance

    $NFE
    $NNI
    $NRDY
    $NSTG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Arcus Biosciences downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Arcus Biosciences from Overweight to Equal Weight and set a new price target of $23.00

    2/12/26 7:22:07 AM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Norwegian Cruise Line downgraded by Barclays with a new price target

    Barclays downgraded Norwegian Cruise Line from Overweight to Equal Weight and set a new price target of $23.00

    2/11/26 7:50:17 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    AutoZone downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded AutoZone from Outperform to Neutral and set a new price target of $3,900.00

    2/9/26 7:54:56 AM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    $NFE
    $NNI
    $NRDY
    $NSTG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $NFE
    $NNI
    $NRDY
    $NSTG
    SEC Filings

    View All

    SEC Form S-3 filed by Arteris Inc.

    S-3 - Arteris, Inc. (0001667011) (Filer)

    2/12/26 5:22:41 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form S-8 filed by Arteris Inc.

    S-8 - Arteris, Inc. (0001667011) (Filer)

    2/12/26 5:20:23 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form S-8 filed by Rivian Automotive Inc.

    S-8 - Rivian Automotive, Inc. / DE (0001874178) (Filer)

    2/12/26 5:10:44 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $NFE
    $NNI
    $NRDY
    $NSTG
    Leadership Updates

    Live Leadership Updates

    View All

    Norwegian Cruise Line Holdings Appoints John W. Chidsey as President and Chief Executive Officer

    MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, today announced that its Board of Directors has appointed John W. Chidsey, a director of NCLH, as President and Chief Executive Officer, effective immediately. Mr. Chidsey succeeds Harry Sommer, who is stepping down as President and Chief Executive Officer and as a Director of NCLH. Mr. Chidsey has a proven track record of leading large global consumer-facing companies through strategic and operational transformation, with experience across franchised operating models, as well as yield-dri

    2/12/26 4:15:00 PM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    Evolv Technology Announces the Appointment of Henrik Kühl as a New Independent Director

    – Long-Time Member of the Board of Directors and Early Venture Capitalist Bilal Zuberi Resigns from Board – Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced the appointment of Mr. Henrik Kühl, age 46, to its Board of Directors ("Board") effective February 12, 2026. Kühl will also serve on the Board's Audit Committee. The Board affirmatively determined that Kühl is independent and an audit committee financial expert as that term is defined by applicable Securities and Exchange Commission regulations. Kühl is an accomplished leader with over 25 years of experience in c

    2/12/26 8:00:00 AM ET
    $AXON
    $EVLV
    Ordnance And Accessories
    Industrials
    Computer peripheral equipment
    Technology

    PubMatic Appoints Marketing Veteran John Petralia as Chief Marketing Officer to Accelerate AI-Driven Growth

    Appointment strengthens commercial leadership as PubMatic scales AI-powered advertising across CTV, mobile and omnichannel media. PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, today announced the appointment of John Petralia as Chief Marketing Officer. Petralia will lead PubMatic's global marketing organization as the company scales AI-powered advertising technology across premium connected TV (CTV), mobile app, and omnichannel media. His appointment comes as publishers and brands move from AI experimentation to live, measurable execution – placing new emphasis on clarity, measurable performance, and trusted scalability. His

    2/12/26 8:00:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    $NFE
    $NNI
    $NRDY
    $NSTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arcus Biosciences Inc.

    SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

    12/17/24 9:52:58 PM ET
    $RCUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $NFE
    $NNI
    $NRDY
    $NSTG
    Financials

    Live finance-specific insights

    View All

    Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026

    ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the fourth quarter and full year 2025 financial and business results on Tuesday, February 24, 2026, at 4:30 p.m. ET. Following management's prepared remarks and discussion of

    2/12/26 4:35:00 PM ET
    $SUPN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Fourth Quarter Ended December 31, 2025

    Bain Capital Specialty Finance, Inc. (NYSE:BCSF, the "Company")) today announced it will report its financial results for the fourth quarter and fiscal year ended December 31, 2025 on Thursday, February 26, 2026 after market close. Management will host a conference call on Friday, February 27, 2026 at 8:00 a.m. Eastern Time to discuss the Company's financial results. Conference Call Information: A conference call to discuss the Company's financial results will be held live at 8:00 a.m. Eastern Time on February 27, 2026. Please visit BCSF's webcast link located on the Events & Presentations page of the Investor Resources section of BCSF's website at http://www.baincapitalspecialtyfinance

    2/12/26 4:30:00 PM ET
    $BCSF
    Finance/Investors Services
    Finance

    Shift4 Announces Date of Fourth Quarter Earnings Results and Upcoming Investor Conference Participation

    Shift4 (NYSE:FOUR) today announced the date for the release of its fourth quarter 2025 financial results. Q4 2025 Earnings Conference Call Shift4 will release its fourth quarter 2025 financial results pre-market open on Thursday, February 26, 2026. Management will also host a conference call at 8:30am ET to review these results. Conference Call Details Toll-free dial-in: +1-800-343-4136 Toll dial-in: +1-203-518-9843 Conference ID: FOURQ425 The earnings conference call will also be webcast and interested parties can join the webcast through Shift4's website at: https://investors.shift4.com X Spaces Simulcast In addition to th

    2/12/26 4:30:00 PM ET
    $FOUR
    Real Estate

    $NFE
    $NNI
    $NRDY
    $NSTG
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Rocket Companies Inc. on Jun 21

    Recently, there has been a series of insider purchases at Rocket Companies Inc. by Director Rizik Matthew. On 2024-06-21, Director Rizik Matthew made a purchase of $8,648 worth of shares, acquiring 622 units at a price of $13.90. This transaction increased his direct ownership by 0.09% to 706,108 units, as reported in SEC Form 4. This purchase indicates confidence from an insider in the company's prospects. Building up to this latest purchase, Rizik Matthew had also bought shares in the previous month. On 2024-05-31, he acquired $4,375 worth of shares (317 units at $13.80), increasing his direct ownership by 0.05% to 702,497 units. Following this, he made purchases on 2024-06-05, 2024-06-07

    6/22/24 7:57:56 PM ET
    $RKT
    Finance: Consumer Services
    Finance

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care

    Insider Trading: Significant Buy at Marchex Inc. on Jun 5

    On June 5, 2024, Miller Edwin A made a significant insider purchase at Marchex Inc., acquiring $272,000 worth of Class B Common Stock, amounting to 200,000 units at a price of $1.36 per unit. This transaction represented a substantial increase in direct ownership by 1,107%, bringing Edwin A's total holdings to 218,066 units as reported in the SEC Form 4. Examining this purchase in the context of previous insider activities reveals interesting patterns worth noting. Horowitz Russell C was granted 15,000 units of Class B Common Stock on October 2, 2023, resulting in a 2% increase in direct ownership to 991,918 units. Similarly, Wisehart Manuel W was granted 15,000 units on the same date, incr

    6/10/24 1:01:02 AM ET
    $MCHX
    Computer Software: Prepackaged Software
    Technology